WWOX基因与妇科肿瘤的研究进展
摘要
WWOX基因是一个跨越了常染色体脆性位点FRA16D的基因,近年来大量研究表明其参与信号转导、细胞周期和细胞凋亡等多个环节的调控,在乳腺癌、卵巢癌、非小细胞肺癌等多种恶性肿瘤的发生、发展中发挥重要作用,被认为是一个新的抑癌基因.本文对WWOX基因与妇科肿瘤的研究进展作一综述,以期为妇科肿瘤的基因治疗提供一种新思路.
出处
《徐州医学院学报》
CAS
2012年第2期136-140,共5页
Acta Academiae Medicinae Xuzhou
基金
徐州市科技发展基金(XF10C086)
参考文献30
-
1Bednarek AK,Laflin KJ,Daniel RL. WWOX,a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1,a region frequently affected in breast cancer[J].Cancer Research,2000,(08):2140-2145.
-
2Chang NS,Schultz L,Hsu LJ. 17β-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro:potential role in cancerous progression of breast and prostate to a premetastatic state in vivo[J].Oncogene,2005,(04):714-723.doi:10.1038/sj.onc.1208124.
-
3Aqeilan RI,Trapasso F,Hussain S. Targeted deletion of WWOX reveals a tumor suppressor function[J].Proceedings of the National Academy of Sciences(USA),2007,(10):3949-3954.
-
4Paige AJ,Taylor KJ,Taylor C. WWOX:a candidate tumor suppressor gene involved in multiple tumor types[J].Proceedings of the National Academy of Sciences(USA),2001,(20):11417-11422.
-
5Ried K,Finnis M,Hobson L. Common chromosomal fragile site FRA16D sequence:identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells[J].Human Molecular Genetics,2000,(11):1651-1663.
-
6Yendamuri S,Kuroki T,Trapasso F. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer[J].Cancer Research,2003,(04):878-881.
-
7Watanabe A,Hoppo Y,Taniguchi H. An opposing view on WWOX protein function as a tumor suppressor[J].Cancer Research,2003,(24):8629-8633.
-
8Pimenta FJ,Gomes DA,Perdigao PF. Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas[J].International Journal of Cancer,2006,(05):1154-1158.
-
9Nagarajan RP,Costello JF. Epigenetic mechanisms in glioblastoma multiforme[J].Seminars in Cancer Biology,2009,(03):188-197.doi:10.1016/j.semcancer.2009.02.005.
-
10Kanai Y. Alterations of DNA methylation and clinicopathological diversity of human cancers[J].Pathology International,2008,(09):544-558.doi:10.1111/j.1440-1827.2008.02270.x.
二级参考文献36
-
1Bednarek A K,Keck-Waggoner C L,Daniel R L,et al.WWO-X,the FRA16D gene,behaves as a suppressor of tumor growth[J].Cancer Res,2001,61(22):8068-8073.
-
2Schmitt E,Cimoli G,Steyaert A,et al.Bcl-xl modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities[J].Exp Cell Res,1998,240(1):107-121.
-
3Yendamuri S,Kuroki T,Trapasso F,et al.WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer[J].Cancer Res,2003,63(4):878-881.
-
4Lewandowska U,Zelazowski M,Seta K,et al.WWOX,the t-umour suppressor gene affected in multiple cancers[J].J Physiol Pharmacol,2009,60(Suppl 1):47-56.
-
5Gourley C,Paige A J,Taylor K J,et al.WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor,although the role of variant 4 remains unclear[J].Int J Oncol,2005,26(6):1681-1689.
-
6Lebedeva I,Rando R,Ojwang J,et al.Bcl-xl in prostate cancer cells:effects of overexpression and down-regulation on chemosensitivity[J].Cancer Res,2000,60(21):6052-6060.
-
7Vilenchik M,Raffo A J,Benimetskaya L,et al.Antisense R-NA down-regulation of Bcl-xl expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents[J].Cancer Res,2002,62(7):2175-2183.
-
8Takehara T,Takahashi H.Suppression of bcl-xl deamidation in human hepatocellular carcinomas[J].Cancer Res,2003,63(12):3054-3057.
-
9Marone M,Scambia G,Mozzet S,et al.Bcl-2,bax,bcl-xl,and bcl-xs expression in normal and neoplastic ovarian tissues[J].Clin Cancer Res,1998,4(2):517-521.
-
10Chang N S,Pratt N,Heath J,et al.Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity[J].J Biol Chem,2001,276(5):3361-3370.
共引文献22
-
1魏新设,陈奎生.宫颈鳞癌组织中Ezrin蛋白的表达及其意义[J].中原医刊,2007,34(17):8-9.
-
2韩君英.年轻妇女子宫内膜不典型增生的孕激素治疗——附36例分析[J].实用肿瘤杂志,2009,24(3):283-285. 被引量:11
-
3袁艳龙,何春年.乳腺与女性生殖系统恶性肿瘤中Ezrin的表达及意义[J].临床与实验病理学杂志,2009,25(3):327-330. 被引量:2
-
4谢放,黄强.染色体脆性位点抑癌基因与肿瘤关系的研究进展[J].中国普通外科杂志,2009,18(10):1069-1071. 被引量:2
-
5陈衡,彭碧玲,黄海玉,黄建.C-Met和脆性组氨酸三联体在卵巢癌中的表达及临床意义[J].中华实用诊断与治疗杂志,2009,23(11):1079-1081. 被引量:4
-
6谢放,黄强.染色体脆性位点抑癌基因FHIT真核表达质粒的构建[J].山东医药,2009,49(42):21-22.
-
7谢放,黄强.FHIT基因转染对胆管癌细胞增殖与侵袭的影响[J].世界华人消化杂志,2009,17(33):3437-3440. 被引量:2
-
8黄海玉,刘小乐,陈衡,彭碧玲.PTEN和FHIT在上皮性卵巢肿瘤中的表达及其临床意义[J].中国妇幼保健,2010,25(5):654-656. 被引量:7
-
9谢放,黄强.体外培养胆管癌细胞中FHIT基因的表达及其意义[J].中国普通外科杂志,2010,19(2):139-142.
-
10黄强,谢放,刘臣海,汤志刚,王世杰,尤昊.脆性组氨酸三联体基因对胆管癌细胞凋亡的影响[J].中华实验外科杂志,2010,27(2):204-206. 被引量:1
-
1张忠寿.膀胱癌患者染色体畸变的研究[J].宜昌医学专科学校学报,1990,18(2):91-94.
-
2Hecht F,常婉莹,梁海.罕见与多态脆性位点和癌[J].国外医学(遗传学分册),1989,12(5):254-255.
-
3王超,何利平.抑癌基因WWOX在结直肠癌中的表达[J].莆田学院学报,2010,17(2):43-47. 被引量:4
-
4陈军,吴飞翔,杨春,覃思繁.肝细胞癌中wwox基因启动子甲基化与蛋白表达的关系[J].世界华人消化杂志,2012,20(35):3588-3593.
-
5刘涛,李燕京,韩宇.HER2在胃癌中的研究进展[J].现代肿瘤医学,2015,23(15):2216-2219. 被引量:5
-
6沈玉琨,孟永济.乳腺癌的诊断方法[J].上海预防医学,1994,6(1):11-12.
-
7李菲,李培义,李宁.针对肿瘤微环境为靶标的治疗策略[J].大家健康(学术版),2015(1):276-277.
-
8马丽,谢淑武,朱焰,曹霖.子宫肌瘤相关研究进展[J].生殖与避孕,2007,27(10):679-683. 被引量:42
-
9周建锋,王怡兵,刘平.Ras蛋白与肝细胞癌变过程中的信号转导[J].中西医结合肝病杂志,2000,10(3):50-52. 被引量:2
-
10张素珍,杨牡丹.晚期食管癌的分子靶向治疗研究进展[J].中国药物与临床,2016,16(6):837-839. 被引量:7